IJE Advance Access published online on March 15, 2006
International Journal of Epidemiology, doi:10.1093/ije/dyl001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Anthropology, Penn State University, University Park, PA 16802, USA
* To whom correspondence should be addressed. Is the search for the causes of complex disease akin to the alchemist's vain quest for the Philosopher's Stone? Complex chronic diseases have tremendous public health impact in the industrialized world. Much effort has been expended on research into their causes, with the aim of predicting who will be affected or preventing effects before they arise, but progress has been halting at best. In this paper, we discuss possible reasons including the use of models and methods that fit point-source and Mendelian diseases but may not be as appropriate for complex diseases, reliance on causal criteria that may not be as relevant as they are for communicable diseases, and the biology of complex disease itself. Finally, we ask whether most complex diseases are even good candidates for the kind of prediction and prevention that we have come to expect based on experience with infectious and Mendelian disease.
Accepted May 31, 2005
Point-Counterpoint
Dissecting complex disease: the quest for the Philosopher's Stone?
Anne V Buchanan 1,
Kenneth M Weiss 2 *,
and
Stephanie M Fullerton 3
2 Department of Anthropology, Penn State University, University Park, PA 16802, USA; Department of Biology, Penn State University, University Park, PA 16802, USA
3 Department of Medical History and Ethics, University of Washington School of Medicine, Seattle, WA 98195, USA
Kenneth M Weiss, E-mail: KenWeiss{at}psu.edu
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in Int. J. Epidemiol.:
- On stones, wands, and promises
- Anne V Buchanan, Kenneth M Weiss, and Stephanie M Fullerton
Int. J. Epidemiol. 2006 10.1093/ije/dyl008.[Abstract]
This article has been cited by other articles:
![]() |
W. Maziak The triumph of the null hypothesis: epidemiology in an age of change Int. J. Epidemiol., April 1, 2009; 38(2): 393 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R Burton, A. L Hansell, I. Fortier, T. A Manolio, M. J Khoury, J. Little, and P. Elliott Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology Int. J. Epidemiol., February 1, 2009; 38(1): 263 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Grammer, W. Marz, W. Renner, B. O. Bohm, and M. M. Hoffmann C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study Eur. Heart J., January 2, 2009; 30(2): 170 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-K. Heng Genome-wide association studies of coronary artery disease: have the results of replication studies been replicable? Eur. Heart J., September 2, 2008; 29(18): 2189 - 2190. [Full Text] [PDF] |
||||
![]() |
K. M. Weiss Tilting at Quixotic Trait Loci (QTL): An Evolutionary Perspective on Genetic Causation Genetics, August 1, 2008; 179(4): 1741 - 1756. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tatsioni, N. G. Bonitsis, and J. P. A. Ioannidis Persistence of Contradicted Claims in the Literature JAMA, December 5, 2007; 298(21): 2517 - 2526. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Morabia Epidemiologic Interactions, Complexity, and the Lonesome Death of Max von Pettenkofer Am. J. Epidemiol., December 1, 2007; 166(11): 1233 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J KHOURY and M. GWINN Genomics, epidemiology, and common complex diseases: let's not throw out the baby with the bathwater! Int. J. Epidemiol., October 1, 2006; 35(5): 1363 - 1364. [Full Text] [PDF] |
||||
![]() |
S. EBRAHIM The future of modern epidemiology: genetics, methods, and history Int. J. Epidemiol., June 1, 2006; 35(3): 511 - 512. [Full Text] [PDF] |
||||
![]() |
D. L Weed Commentary: Rethinking epidemiology Int. J. Epidemiol., June 1, 2006; 35(3): 583 - 586. [Full Text] [PDF] |
||||
![]() |
J. P A Ioannidis Commentary: Grading the credibility of molecular evidence for complex diseases Int. J. Epidemiol., June 1, 2006; 35(3): 572 - 578. [Full Text] [PDF] |
||||
![]() |
D. Coggon Commentary: Complex disease--responding to the challenge Int. J. Epidemiol., June 1, 2006; 35(3): 581 - 583. [Full Text] [PDF] |
||||
![]() |
S. Schwartz and E. Susser Commentary: What can epidemiology accomplish? Int. J. Epidemiol., June 1, 2006; 35(3): 587 - 590. [Full Text] [PDF] |
||||
![]() |
R. C Millikan Commentary: The Human Genome: philosopher's stone or magic wand? Int. J. Epidemiol., June 1, 2006; 35(3): 578 - 581. [Full Text] [PDF] |
||||
![]() |
K. R. Merikangas, N. C.P. Low, and J. Hardy Commentary: Understanding sources of complexity in chronic diseases--the importance of integration of genetics and epidemiology Int. J. Epidemiol., June 1, 2006; 35(3): 590 - 592. [Full Text] [PDF] |
||||
![]() |
A. V Buchanan, K. M Weiss, and S. M Fullerton On stones, wands, and promises Int. J. Epidemiol., June 1, 2006; 35(3): 593 - 596. [Full Text] [PDF] |
||||
![]() |
R. Saracci Everything should be made as simple as possible but not simpler Int. J. Epidemiol., June 1, 2006; 35(3): 513 - 514. [Full Text] [PDF] |
||||




